PFG Investments LLC Has $304,000 Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

PFG Investments LLC grew its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 3.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 33,916 shares of the pharmacy operator’s stock after buying an additional 1,245 shares during the quarter. PFG Investments LLC’s holdings in Walgreens Boots Alliance were worth $304,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. First Trust Direct Indexing L.P. lifted its stake in Walgreens Boots Alliance by 1.9% during the 1st quarter. First Trust Direct Indexing L.P. now owns 32,085 shares of the pharmacy operator’s stock valued at $696,000 after acquiring an additional 597 shares in the last quarter. FinTrust Capital Advisors LLC lifted its position in shares of Walgreens Boots Alliance by 60.4% during the first quarter. FinTrust Capital Advisors LLC now owns 2,130 shares of the pharmacy operator’s stock valued at $46,000 after purchasing an additional 802 shares in the last quarter. Redwood Investment Management LLC lifted its position in shares of Walgreens Boots Alliance by 0.9% during the first quarter. Redwood Investment Management LLC now owns 99,661 shares of the pharmacy operator’s stock valued at $2,162,000 after purchasing an additional 850 shares in the last quarter. Empirical Finance LLC grew its position in Walgreens Boots Alliance by 3.5% in the 1st quarter. Empirical Finance LLC now owns 26,093 shares of the pharmacy operator’s stock worth $566,000 after purchasing an additional 888 shares in the last quarter. Finally, Inlet Private Wealth LLC increased its stake in Walgreens Boots Alliance by 1.9% in the 2nd quarter. Inlet Private Wealth LLC now owns 47,820 shares of the pharmacy operator’s stock valued at $578,000 after buying an additional 900 shares during the last quarter. 58.59% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of brokerages have recently weighed in on WBA. UBS Group boosted their target price on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a research note on Thursday, October 17th. Morgan Stanley cut their price objective on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a research report on Friday, October 11th. JPMorgan Chase & Co. decreased their target price on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a research report on Friday, August 30th. Jefferies Financial Group cut their price target on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a report on Wednesday, October 23rd. Finally, TD Cowen decreased their price objective on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a report on Tuesday, October 22nd. Four equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $12.88.

Walgreens Boots Alliance Stock Performance

Shares of WBA stock opened at $9.24 on Thursday. The firm’s 50 day moving average is $9.23 and its 200 day moving average is $12.59. The stock has a market capitalization of $7.99 billion, a P/E ratio of -0.92, a PEG ratio of 1.20 and a beta of 0.70. Walgreens Boots Alliance, Inc. has a 12 month low of $8.22 and a 12 month high of $27.05. The company has a current ratio of 0.68, a quick ratio of 0.37 and a debt-to-equity ratio of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.03. The firm had revenue of $37.50 billion for the quarter, compared to the consensus estimate of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The business’s quarterly revenue was up 5.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.67 earnings per share. On average, sell-side analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.54 earnings per share for the current year.

Walgreens Boots Alliance Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 12th. Shareholders of record on Monday, November 18th will be paid a $0.25 dividend. The ex-dividend date of this dividend is Monday, November 18th. This represents a $1.00 annualized dividend and a yield of 10.82%. Walgreens Boots Alliance’s dividend payout ratio is currently -9.99%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.